Ca2+-mediated action of long-chain acyl-CoA on liver mitochondria energy-linked processes

Biochim Biophys Acta. 1989 Feb 28;973(2):185-8. doi: 10.1016/s0005-2728(89)80420-7.

Abstract

The decrease of steady-state transmembrane potential (delta psi) and loss of accumulated Ca2+ are magnified if palmitoyl-CoA is added to rat liver mitochondria exposed to Ca2+ and phosphate. The extent of this damage increases with increasing concentration of long-chain acyl-CoA. Addition of L-carnitine with or without the addition of palmitoyl-CoA considerably delays the deenergization. In the latter case, there is a substantial decrease in the assayed endogenous long-chain acyl-CoA content. This protective action of L-carnitine is abolished by L-aminocarnitine, a powerful inhibitor of carnitine palmitoyl transferase (palmitoyl-CoA: L-carnitine O-palmitoyltransferase, EC 2.3.1.21.). The removal of Ca2+ by EGTA, or the inhibition of its uptake by Ruthenium red or Mg2+ further enhances the degree of protection.

MeSH terms

  • Acyl Coenzyme A / pharmacology*
  • Animals
  • Betaine / analogs & derivatives
  • Betaine / pharmacology
  • Calcium / pharmacology*
  • Carnitine / pharmacology
  • Carnitine O-Palmitoyltransferase / antagonists & inhibitors
  • Egtazic Acid / pharmacology
  • Energy Metabolism / drug effects*
  • Magnesium / pharmacology
  • Membrane Potentials / drug effects
  • Mitochondria, Liver / drug effects
  • Mitochondria, Liver / metabolism*
  • Palmitoyl Coenzyme A / pharmacology*
  • Phosphates / pharmacology
  • Rats
  • Ruthenium Red / pharmacology

Substances

  • Acyl Coenzyme A
  • Phosphates
  • Ruthenium Red
  • Palmitoyl Coenzyme A
  • Betaine
  • Egtazic Acid
  • emeriamine
  • Carnitine O-Palmitoyltransferase
  • Magnesium
  • Carnitine
  • Calcium